Skip to content

A study for the therapeutic evaluation and the the selection of micro RNA of the SLFM granule to treat patients of qi deficiency, blood stasis and plegm heat disturbing paroxysmal atrial fibrillation

A study for the therapeutic evaluation and the the selection of micro RNA of the SLFM granule to treat patients of qi deficiency, blood stasis and plegm heat disturbing paroxysmal atrial fibrillation

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900021500
Enrollment
Unknown
Registered
2019-02-24
Start date
2019-02-19
Completion date
Unknown
Last updated
2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Interventions

Intervention group:SLFM Granule
Control group:No

Sponsors

Oriental Hospital, Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with atrial fibrillation and the syndromes of qi deficiency and blood stasis, interior disturbance of phlegm heat; 2. Recur 2 times at least in one month; 3. Aged 18-80 years. 4. Provide written consent.

Exclusion criteria

Exclusion criteria: 1. Patients with severe and malignant arrhythmias:second degree or higher atrial-ventricular blocks,paroxysmal ventricular tachycardia,torsive ventricular tachycardia; 2. Patients with heart failure(NYHA functional ClassIII-IV), heart attack,cerebrovascular surgery or trauma in three month; 3. Patients with hypertrophic cardiomyopathy,dilated cardiomyopathy,pre-excitation syndrome,severe anemia,viral myocarditis,or hyperthyroidism; 4. Patients have taken anti-arrhythmia medicines; 5. Patients with severe liver,kidney,hematopoietic system, nervous system or other primary diseases and patients with malignant tumors; 6. Patients with acute or chronic infection; 7. Pregnant or lactating women; 8. Participation in other clinical tirals within 3 month.

Design outcomes

Primary

MeasureTime frame
Total af load;

Secondary

MeasureTime frame
Total number of atrial fibrillation;Total duration of atrial fibrillation;simultaneous phenomenon;left atrial diameter;right atrial diameter;Score of palpitation in Chinese medicine;SF-36 quality of life;CRP;IL-6;TNF-a;

Countries

China

Contacts

Public ContactJing Liu

Oriental Hospital, Beijing University of Chinese Medicine

liujingth@sina.com+86 13161161811

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026